Genetic predeterminations of head and neck cancer;Uwarunkowania genetyczne nowotworów głowy i szyi

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 62, Issue , 2008, Pages 490-501

  Rusin, Paweł ^a   Markiewicz, Łukasz ^a   Majsterek, Ireneusz ^a,b  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

DNA damage and repair; Genetic susceptibility; Head and neck cancer

Indexed keywords

XENOBIOTIC AGENT;

GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; HUMAN; METABOLISM; POLAND; PREVALENCE; REVIEW; RISK FACTOR;

GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; POLAND; POLYMORPHISM, GENETIC; PREVALENCE; RISK FACTORS; XENOBIOTICS;

EID: 58149374101     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Akervall J.A., Jin Y., Wennerberg J.P., Zätterström U.K., Kjellén E., Mertens F., Willén R., Mandahl N., Heim S., Mitelman F.: Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer, 1995; 76: 853-859
2. Allegra E., Garozzo A., Lombardo N., De Clemente M., Carey T.E.: Mutations and polymorphisms in mitochondrial DNA in head and neck cancer cell lines. Acta Otorhinolaryngol. Ital., 2006; 26: 185-190
3. Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N., Turnbull D.M., Howell N.: Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet., 1999; 23: 147
4. Benhamou S., Lee W.J., Alexandrie A.K., Boffetta P., Bouchardy C., Butkiewicz D., Brockmöller J., Clapper M.L., Daly A., Dolzan V., Ford J., Gaspari L., Haugen A., Hirvonen A., Husgafvel-Pursiainen K., Ingelman-Sundberg M., Kalina I., Kihara M., Kremers P., Le Marchand L., London S.J., Nazar-Stewart V., Onon-Kihara M., Rannug A., Romkes M., Ryberg D., Seidegard J., Shields P., Strange R.C., Stücker I., To-Figueras J., Brennan P., Taioli E.: Meta-and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis, 2002; 23: 1343-1350
5. Bianchi N.O., Bianchi M.S., Richard S.M.: Mitochondrial genome instability in human cancers. Mutat. Res., 2001; 488: 9-23
6. Bockmühl U., Schwendel A., Dietel M., Petersen I.: Distinct patterns of chromosomal alterations in high-and low-grade head and neck squamous cell carcinomas. Cancer Res., 1996; 56: 5325-5329
7. Buerger H., Gebhardt F., Schmidt H., Beckmann A., Hutmacher K., Simon R., Lelle R., Boecker W., Brandt B.: Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression. Cancer Res., 2000; 60: 854-857
8. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., Corio R., Lee D., Greenberg B., Koch W., Sidransky D.: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res., 1996; 56: 2488-2492
9. Capoluongo E., Almadori G., Concolino P., Bussu F., Santonocito C., Vendittelli F., Galli J., Zuppi C., Ameglio F., Paludetti G., Giardina B.: GSTT1 and GSTM1 allelic polymorphisms in head and neck cancer patients from Italian Lazio Region. Clin. Chim. Acta, 2007; 376: 174-178
10. Cascorbi I., Henning S., Brockmöller J., Gephart J., Meisel C., Müller J.M., Loddenkemper R., Roots I.: Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of myeloperoxidase gene. Cancer Res., 2000; 60: 644-649
11. Cavaciuti E., Laugé A., Janin N., Ossian K., Hall J., Stoppa-Lyonnet D., Andrieu N.: Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families. Genes Chromosomes Cancer, 2005; 42: 1-9
12. Cho E.Y., Hildesheim A., Chen C.J., Hsu M.M., Chen I.H., Mittl B.F., Levine P.H., Liu M.Y., Chen J.Y., Brinton L.A., Cheng Y.J., Yang C.S.: Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol. Biomarkers Prev., 2003; 12: 1100-1104
13. Cloos J., Reid C.B., Snow G.B., Braakhuis B.J.: Mutagen sensitivity: enhanced risk assessment of squamous cell carcinoma. Eur. J. Cancer B Oral Oncol., 1996; 32B: 367-372
14. Corde S., Biston M.C., Elleaume H., Estève F., Charvet A.M., Joubert A., Ducros V., Bohic S., Simionovici A., Brochard T., Nemoz C., Renier M., Troprès I., Fiedler S., Bravin A., Thomlinson W., Le Bas J.F., Balosso J.: Lack of cell death enhancement after irradiation with monochromatic synchrotron X rays at the K-shell edge of platinum incorporated in living SQ20B human cells as cis-diamminedichloroplatinum( II). Radiat. Res., 2002; 158: 763-770
15. Dzidkowska J., Wojciechowska U., Tarkowski W., Zatoński W.A.: Nowotwory złos̈liwe w Polsce w 2000 roku. Centrum Onkologii-Instytut, Warszawa, 2003
16. Elahi A., Bendaly J., Zheng Z., Muscat J.E., Richie J.P. Jr., Schantz S.P., Lazarus P.: Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk. Cancer, 2003; 98: 872-880
17. Etienne-Grimaldi M.C., Pereira S., Magné N., Formento J.L., Francoual M., Fontana X., Demard F., Dassonville O., Poissonnet G., Santini J., Bensadoun R.J., Szepetowski P., Milano G.: Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients. Ann. Oncol., 2005; 16: 934-941
18. Gal T.J., Huang W.Y., Chen Ch., Hayes R.B., Schwartz S.M.: DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Laryngoscope, 2005; 115: 2221-2231
19. Garden A.S., Asper J.A., Morrison W.H., Schechter N.R., Glisson B.S., Kies M.S., Myers J.N., Ang K.K.: Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Cancer, 2004; 100: 1171-1178
20. Gebhardt F., Bürger H., Brandt B.: Modulation of EGFR gene transcription by secondary structures, a polymorphic repetitive sequence and mutations-A link between genetics and epigenetics. Histol. Histopathol., 2000; 15: 929-936
21. Geisler S.A., Olshan A.F., Cai J., Weissler M., Smith J., Bell D.: Glutathione S-transferase polymorphisms and survival from head and neck cancer. Head Neck, 2005; 27: 232-242
22. Giefing M., Wierzbicka M., Szyfter K.: Drugie pierwotne nowotwory gowy i szyi-przegld teorii wyjaniajcych ich powstawanie oraz najnowszej terminologii. Wspócz. Onkol., 2004; 8: 466-474
23. Gollin S.M.: Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck, 2001; 23: 238-253
24. Hao D., Ritter M.A., Oliver T., Browman G.P.: Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus. Semin. Radiat. Oncol., 2006; 16: 10-19
25. Harari P.M., Ritter M.A., Petereit D.G., Mehta M.P.: Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations. Curr. Probl. Cancer, 2004; 28: 7-40
26. Hashibe M., Brennan P., Strange R.C., Bhisey R., Cascorbi I., Lazarus P., Oude Ophuis M.B., Benhamou S., Foulkes W.D., Katoh T., Coutelle C., Romkes M., Gaspari L., Taioli E., Boffetta P.: Meta-and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol. Biomarkers Prev., 2003; 12: 1509-1517
27. Hayes J.D., Strange R.C.: Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology, 2000; 61: 154-166
28. Homann N., Nees M., Conradt C., Dietz A., Weidauer H., Maier H., Bosch F.X.: Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Clin. Cancer Res., 2001; 7: 290-296
29. Hsieh L.L., Chien H.T., Chen I.H., Liao C.T., Wang H.M., Jung S.M., Wang P.F., Chang J.T., Chen M.C., Cheng A.J.: The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. Cancer Epidemiol. Biomarkers Prev., 2003; 12: 439-443
30. Iwakawa M., Goto M., Noda S., Sagara M., Yamada S., Yamamoto N., Kawakami Y., Matsui Y., Miyazawa Y., Yamazaki H., Tsuji H., Ohno T., Mizoe J., Tsujii H., Imai T.: DNA repair capacity measured by high throughput alkaline comet assays in EBV-transformed cell lines and peripheral blood cells from cancer patients and healthy volunteers. Mutat. Res., 2005; 588: 1-6
31. Jassem J., Kawecki A., Krzakowski M.(red.): Nowotwory nabonkowe narzdów gowy i szyi. W: Zalecenia postêpowania diagnostyczno-terapeutycznego w nowotworach zoliwych u dorosych. Polska Unia Onkologii, Warszawa, 2003; 11-25
32. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., Feuer E.J., Thun M.J.: Cancer statistics, 2004. CA Cancer J. Clin., 2004; 54: 8-29
33. Kastan M.B., Bartek J.: Cell-cycle checkpoints and cancer. Nature, 2004; 432: 316-323
34. Kawecki A.: Ocena skutecznoci i wskazañ do chemioterapii chorych na nawrotowe i rozsiane raki narzdów gowy i szyi. Nowotwory, 2001; 51: 1-65
35. Kujawski M., Jarmu M., Rydzanicz M., Szukaa K., Wierzbicka M., Grenman R., Golusiñski W., Szyfter K.: Frequent chromosome Y loss in primary, second primary and metastatic squamous cell carcinomas of the head and neck region. Cancer Lett., 2004; 208: 95-101
36. Lewis P.D., Baxter P., Griffiths P.A., Parry J.M., Skibiñski D.O.: Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin's tumour. J. Pathol. 2000; 191: 274-281
37. Lynch H.T., de la Chapelle A.: Hereditary colorectal cancer. N. Engl. J. Med., 2003; 348: 919-932
38. Markiewicz Z., Kwiatkowski Z.A.: Bakterie, antybiotyki, lekoopornoæ. PWN, Warszawa, 2001
39. Meredith S.D., Levine P.A., Burns J.A., Gaffey M.J., Boyd J.C., Weiss L.M., Erickson N.L., Williams M.E.: Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch. Otolaryngol. Head Neck Surg., 1995; 121: 790-794
40. Moreland N.J., Illand M., Kim Y.T., Paul J., Brown R.: Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin. Cancer Res., 1999; 59: 2102-2106
41. Mornstad H., Pfeiffer H., Yoon C., Teivens A.: Demonstration and semi-quantification of mtDNA from human dentine and its relation to age. Int. J. Legal Med., 1999; 112: 98-100
42. Namazie A., Alavi S., Olopade O.I., Pauletti G., Aghamohammadi N., Aghamohammadi M., Gornbein J.A., Calcaterra TC., Slamon D.J., Wang M.B., Srivatsan E.S.: Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope, 2002; 112: 472-481
43. Nanda R., Huo D., Cook M., Chen L., Hope K., Cummings S., Olopade O.I.: Outcomes after breast cancer in an ethnically diverse cohort of high-risk patients: Differences in survival based on BRCA1/BRCA2 mutation status. J. Clin. Oncol., 2007; 25, 18S
44. Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., Bigner S.H., Davidson N., Baylin S., Devilee P., Glover T., Collins F.S., Weslon A., Modali R., Harris C.C., Vogelstein B.: Mutations in the p53 gene occur in diverse human tumour types. Nature, 1989; 342: 705-708
45. Nikjoo H., O'Neill P., Wilson W.E., Goodhead D.T.: Computational approach for determining the spectrum of DNA damage induced by ionizing radiation. Radiat. Res., 2001; 156: 577-583
46. Nowacka-Zawisza M., Bry M., Romanowicz-Makowska H., Kulig A., Krajewska W.M.: Genetic instability in the RAD51 and BRCA1 regions in breast cancer. Cell. Mol. Biol. Lett., 2007; 12: 192-205
47. Olivier M., Hussain S.P., Caron de Fromentel C., Hainaut P., Harris C.C.: TP53 mutation spectra and load: A tool for generating hypotheses on the etiology of cancer. IARC Sci. Publ., 2004; 157: 247-270
48. Palyvoda O., Mukalov I., Polanska J., Wygoda A., Drobot L., Widel M., Rzeszowska-Wolny J.: Radiation-induced DNA damage and its repair in lymphocytes of patients with head and neck cancer and healthy donors. Anticancer Res., 2002; 22: 1721-1725
49. Parkin D.M., Bray F., Ferlay J., Pisani P.: Global cancer statistics, 2002. CA Cancer J. Clin., 2005; 55: 74-108
50. Peltomäki P.: Role of DNA mismatch repair defects in the pathogenesis of human cancer. J. Clin. Oncol., 2003; 21: 1174-1179
51. Pignon J.P., Bourhis J., Domenge C., Designe L.: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet, 2000; 355: 949-955
52. Pomerantz G.R., Grandis J.R.: The role of epidermal growth factor receptor in head and neck squamous cell carcinoma. Curr. Oncol. Rep., 2003; 5: 140-146
53. Remenár E., Számel I., Budai B., Vincze B., Gaudi I., Gundy S., Kásler M.: Increase of hypophyseal hormone levels in male head and neck cancer patients. Pathol. Oncol. Res., 2007; 13: 341-344
54. Rubin J.S., Qiu L., Etkind P.: Amplification of the Int-2 gene in head and neck squamous cell carcinoma. J. Laryngol. Otol., 1995; 109: 72-76
55. Rusin P., Olszewski J., Morawiec-Bajda A., Przybylowska K., Kaczmarczyk D., Golinska A., Majsterek I.: DNA damage and repair in head and neck squamous cell carcinoma (HNSCC) after radiation tratment: Clinical applications. Head Neck, 2008; (w druku)
56. Rydzanicz M., Wierzbicka M., Gajêcka M., Szyfter W., Szyfter K.: The impact of genetic factors on the incidence of multiple primary tumors (MTP) of the head and neck. Cancer Lett., 2005; 224: 263-278
57. Saha D.T., Davidson B.J., Wang A., Pollock A.J., Orden R.A., Goldman R.: Quantification of DNA repair capacity in whole blood of patients with head and neck cancer and healthy donors by comet assay. Mutat. Res., 2008; 650: 55-62
58. Sawyer D.E., Van Houten B.: Repair of DNA damage in mitochondria. Mutat. Res., 1999; 434: 161-176
59. Shin D.M., Charuruks N., Lippman S.M., Lee J.J., Ro J.Y., Hong W.K., Hittelman W.N.: p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis. Cancer Epidemiol. Biomarkers Prev., 2001; 10: 603-609
60. Singh M., Shah P.P, Singh A.P., Ruwali M., Mathur N., Pant M.C., Parmar D.: Association of genetic polymorphisms in glutathione Stransferases and susceptibility to head and neck cancer. Mutat. Res., 2008; 638: 184-194
61. Sturgis E.M., Clayman G.L., Guan Y., Guo Z., Wei Q.: DNA repair in lymphoblastoid cell lines from patients with head and neck cancer. Arch. Otolaryngol. Head Neck Surg., 1999; 125: 185-190
62. Sturgis E.M., Zheng R., Li L., Castillo E.J., Eicher S.A., Chen M., Strom S.S., Spitz M.R., Wei Q.: XPD/ERCC2 polymorphisms and risk of head and neck cancer: A case-control analysis. Carcinogenesis, 2000; 21: 2219-2223
63. Szawowski A., Szmidt J. (red.): Zasady diagnostyki i chirurgicznego leczenia nowotworów w Polsce. Fundacja-Polski Przegld Chirurgiczny, Warszawa, 2003
64. Szutkowski Z., Kawecki A., Fijuth J.: Powtórne napromienianie nowotworów terenu gowy i szyi. Nowotwory, 1998; 48: 917-922
65. Szyfter K.: Rola czynnika genetycznego w powstawaniu i przebiegu paskonabonkowego raka krtani. Postêpy chirurgii gowy szyi, 2002; 1: 5-19
66. Szyfter K., Jaskula-Sztul R., Kujawski M.: Czynnik genetyczny w raku krtani. Post. Biol. Kom., 1998, 25: 123-136
67. Tai H.C., Hsieh C.H., Clifford Chao K.S., Liu S.H., Leu Y.S., Chang Y.F., Hsiao H.T., Chang Y.C., Yc Huang D., Chen Y.J., Comparison of radiotherapy strategies for locally advanced hypopharyngeal cancer after resection and ileocolic flap reconstruction. Acta Otolaryngol., 2008; 13: 1-7
68. To-Figueras J., Gene M., Gómez-Catalán J., Piqué E., Borrego N., Caballero M., Cruellas F., Raya A., Dicenta M., Corbella J.: Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk. Cancer Lett., 2002; 187: 95-101
69. Turchi J.J., Henkels K.M., Zhou Y.: Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK. Nucleic Acids Res., 2000; 28: 4634-4641
70. Van Dyck E., Stasiak A.Z., Stasiak A., West S.C.: Binding of doublestrand breaks in DNA by human Rad52 protein. Nature, 1999; 398: 728-731
71. Wei Q., Eicher S.A., Guan Y., Cheng L., Xu J., Young L.N., Saunders K.C., Jiang H., Hong W.K., Spitz M.R., Strom S.S.: Reduced expression of hMLH1 and hGTBP/hMSH6: A risk factor for head and neck cancer. Cancer Epidemiol. Biomarkers Prev., 1998; 7: 309-314
72. Wenghoefer M., Pesch B., Harth V., Broede P., Fronhoffs S., Landt O., Brüning T., Abel J., Bolt H.M., Herberhold C., Vetter H., Ko Y.D.: Association between head and neck cancer and microsomal epoxide hydrolase genotypes. Arch. Toxicol., 2003; 77: 37-41
73. Wierzbicka M., Szyfter W., Bieñ S., Maciejewski B., Skadowski K., Milecki P.: Zalecenia diagnostyczno-terapeutyczne dla wybranych nowotworów gowy i szyi. Post. Chir. Gowy i Szyi, 2006; 5: 6-39
74. Xia W., Lau Y.K., Zhang H.Z., Liu A.R., Li L., Kiyokawa N., Clayman G.L., Katz R.L., Hung M.C.: Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin. Cancer Res., 1997; 3: 3-9
75. Yu G.P., Zhang Z.F., Hsu T.C., Spitz M.R., Schantz S.P.: Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett., 1999; 146: 93-101
76. Yu Z., Weinberger P.M., Haffty B.G., Sasaki C., Zerillo C., Joe J., Kowalski D., Dziura J., Camp R.L., Rimm D.L., Psyrri A.: Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin. Cancer Res., 2005; 11: 1160-1166
77. Zastawny T.H., Dbrowska M., Jaskólski T., Klimarczyk M., Kuliñski L., Koszela A., Szczêniewicz M., liwiñska M., Witkowski P., Oliñski R.: Comparison of oxidative base damage in mitochondrial and nuclear DNA. Free Rad. Biol. Med., 1998; 24: 722-725
78. Zheng Z., Park J.Y., Guillemette C., Schantz S.P., Lazarus P.: Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J. Natl. Cancer Inst., 2001; 19: 1411-1418